Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

Moffitt Cancer Center posts $238.4M operating income in fiscal 2026

Moffitt Cancer Center reported higher fiscal 2026 revenue, operating income and net income as patient service revenue and nonoperating gains rose.

By Dr. Revathy Mohan V.R., MBBS · Oct 21, 2026 · 5 min read

Oncology·MHRA

Breast Cancer CNS Role Marks GenesisCare Leeds Expansion

GenesisCare is hiring a founding breast cancer CNS in Leeds to build pathways, coordinate care and support patients…

Oct 21, 2026

Oncology·ScienceDaily

Immunotherapy Arthritis May Recur Through Immune Memory, Study Finds

Recurrent arthritis after cancer immunotherapy may reflect immune memory in joint T cells, opening a path to targeted…

Oct 21, 2026

Oncology·Becker H

Cancer drug shortages worsen as chemotherapy disruptions deepen, ASHP says

ASHP’s Q3 report shows chemotherapy shortages rising again, with manufacturing disruptions, demand spikes and staffing strain complicating cancer…

Oct 21, 2026

Oncology·MedCity

FDA Approves GSK Jemperli for Locally Advanced Rectal Cancer

FDA grants accelerated approval to GSK’s Jemperli for MSI-H or dMMR locally advanced rectal cancer, expanding an option…

Oct 21, 2026

Oncology·STAT

Dana-Farber and Beth Israel start work on new $1.68 billion cancer hospital

Dana-Farber and Beth Israel Lahey Health have begun construction on a $1.68 billion Boston cancer hospital, reshaping regional…

Oct 21, 2026

Oncology·Cancer Cell

RUNX1 Loss Reprograms Enhancers and Weakens Epithelial Stability in Cancer Study

Cell Press study links acute RUNX1 loss to enhancer reprogramming, epithelial destabilization, and early cancer-associated phenotypes.

Oct 21, 2026

Oncology·Cancer Cell

Lipid Metabolism Nano-Delivery Platforms Expand Therapeutic Targeting Options

A 2025 review examines multifunctional nano-delivery platforms for targeting lipid metabolism in metabolic disease, cancer, and other conditions.

Oct 21, 2026

Oncology·Cancer Cell

AI in Spatial Transcriptomics Gains Ground Across Cancer Research

A review in Briefings in Bioinformatics examines how AI and machine learning are reshaping spatial transcriptomics analysis, from…

Oct 21, 2026

Oncology·Cancer Cell

Nanoparticle Safety in Medicine Demands Earlier Translational Controls

A review in nanomedicine calls for earlier safety-by-design, better characterization, and patient-specific risk assessment before clinical translation.

Oct 21, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.